The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.

Benchmark analyst Robert Wasserman maintained a Buy rating on Immunoprecise Antibodies Ltd. (NASDAQ:IPA) with a price target ...